期刊
VIRUSES-BASEL
卷 14, 期 5, 页码 -出版社
MDPI
DOI: 10.3390/v14050989
关键词
virus-like particle; foot-and-mouth disease; foot-and-mouth disease virus; vaccine; swine; cattle; platform; mammalian cell culture; plasmid; DIVA
类别
资金
- U.S. DHS Science and Technology Directorate (ST) [HSHQDC-14-00035, HSHQPM-14-X-00001, 70RSAT19D00000004]
This report describes a plasmid-based virus-like particle (VLP) production platform that combines the advantages of nucleic-acid-based vaccines with intact capsid epitopes, and can quickly adapt to new viral strains and serotypes.
RNA viruses, such as foot-and-mouth disease virus (FMDV), have error-prone replication resulting in the continuous emergence of new viral strains capable of evading current vaccine coverage. Vaccine formulations must be regularly updated, which is both costly and technically challenging for many vaccine platforms. In this report, we describe a plasmid-based virus-like particle (VLP) production platform utilizing transiently transfected mammalian cell cultures that combines both the rapid response adaptability of nucleic-acid-based vaccines with the ability to produce intact capsid epitopes required for immunity. Formulated vaccines which employed this platform conferred complete protection from clinical foot-and-mouth disease in both swine and cattle. This novel platform can be quickly adapted to new viral strains and serotypes through targeted exchanges of only the FMDV capsid polypeptide nucleic acid sequences, from which processed structural capsid proteins are derived. This platform obviates the need for high biocontainment manufacturing facilities to produce inactivated whole-virus vaccines from infected mammalian cell cultures, which requires upstream expansion and downstream concentration of large quantities of live virulent viruses.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据